The short-term oral toxicity of a recently identified environmental polluta
nt, bis(4-chloro- phenyl) sulfone (BCPS), was studied. Groups of male Sprag
ue-Dawley rats (n = 6) were administered BCPS via the diet at 0 (control),
10, 100 or 1000 ppm for 4 wk. Additional control and 1000 ppm groups were a
lso treated for 1, 2, and 3 wk. At termination, high-dose animals showed de
pressed growth rate and food consumption, and 1 high dose animal in each of
the wk-1, -3, and -4 groups had marked hematuria. Increased liver to body
weight ratio was present at 100 ppm and increased kidney to body weight rat
io at 1000 ppm. Marked increases in hepatic benzoylresorufin O-dealkylase (
BROD) and pentoxyresorufin O-dealkylase (PROD) activities were detected sta
rting at 10 ppm. There was a significant decrease in methoxyresorufin O-dea
lkylase (MROD) activity at 1000 ppm. Hepatic UDP-glucuronosyltransferase (U
DPGT) and glutathione S-transferase (GST) activities also increased startin
g at 100 ppm. A marked increase in urinary excretion of ascorbic acid was a
pparent starting at 10 ppm, while there were no changer in urinary N-acetyl
glucosaminidase (NAC) activity and protein levels. A threefold increase in
serum cholesterol and a 30% increase in platelet counts were observed in th
e 1000 ppm group. Levels of thiobarbituric acid-reactive substances (TBARS)
were increased by threefold in the liver of the high-dose animals but were
not significantly altered in the serum. Tissue BCPS concentrations were do
se dependent and followed the order: adipose tissue >> liver > kidneys > br
ain, spleen, lungs, in the time-course study involving the control and high
-dose groups, most of the treatment effects were clearly present in wk I, a
nd the severity of the effects remained at more or less the same levels the
reafter. The exceptions were hepatic BROD and PROD activities, which showed
a trend toward further increases with time of treatment. Liver and adipose
tissue concentrations of BCPS remained unchanged from wk I to wk 4, while
kidney concentrations increased with time. The results indicated that BCPS
produced hepatic effects at the lowest dose level tested (10 ppm in the die
t or 0.8 mg/kg/d).